Analysen von Keyur Parekh

16.05.22 Valneva Buy Goldman Sachs Group Inc.
12.05.22 Merck Sell Goldman Sachs Group Inc.
12.05.22 Sanofi Buy Goldman Sachs Group Inc.
11.05.22 Bayer Buy Goldman Sachs Group Inc.
11.05.22 Roche Conviction Buy List Goldman Sachs Group Inc.
10.05.22 Bayer Buy Goldman Sachs Group Inc.
05.05.22 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
29.04.22 AstraZeneca Sell Goldman Sachs Group Inc.
Werbung
29.04.22 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
28.04.22 Sanofi Buy Goldman Sachs Group Inc.
28.04.22 Novartis Conviction Buy List Goldman Sachs Group Inc.
27.04.22 Roche Conviction Buy List Goldman Sachs Group Inc.
25.04.22 Roche Conviction Buy List Goldman Sachs Group Inc.
12.04.22 Sanofi Buy Goldman Sachs Group Inc.
12.04.22 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
12.04.22 Roche Conviction Buy List Goldman Sachs Group Inc.
04.04.22 Novartis Conviction Buy List Goldman Sachs Group Inc.
01.04.22 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
30.03.22 Roche Conviction Buy List Goldman Sachs Group Inc.
29.03.22 Sanofi Buy Goldman Sachs Group Inc.
04.03.22 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
03.03.22 Merck Sell Goldman Sachs Group Inc.
01.03.22 Bayer Buy Goldman Sachs Group Inc.
10.02.22 AstraZeneca Sell Goldman Sachs Group Inc.
09.02.22 Merck Sell Goldman Sachs Group Inc.
04.02.22 Sanofi Buy Goldman Sachs Group Inc.
03.02.22 Roche Conviction Buy List Goldman Sachs Group Inc.
02.02.22 Novartis Conviction Buy List Goldman Sachs Group Inc.
02.02.22 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
27.01.22 Sanofi Buy Goldman Sachs Group Inc.
26.01.22 Roche Conviction Buy List Goldman Sachs Group Inc.
26.01.22 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
25.01.22 Novartis Conviction Buy List Goldman Sachs Group Inc.
07.01.22 GlaxoSmithKline Buy Goldman Sachs Group Inc.
23.12.21 Novartis Conviction Buy List Goldman Sachs Group Inc.
16.12.21 Novartis Conviction Buy List Goldman Sachs Group Inc.
16.12.21 Roche Conviction Buy List Goldman Sachs Group Inc.
16.12.21 Novartis Conviction Buy List Goldman Sachs Group Inc.
14.12.21 GlaxoSmithKline Buy Goldman Sachs Group Inc.
10.12.21 Roche Conviction Buy List Goldman Sachs Group Inc.
07.12.21 GlaxoSmithKline Buy Goldman Sachs Group Inc.
22.11.21 Merck Sell Goldman Sachs Group Inc.
22.11.21 Bayer Buy Goldman Sachs Group Inc.
18.11.21 Novo Nordisk Conviction Buy List Goldman Sachs Group Inc.
12.11.21 AstraZeneca Sell Goldman Sachs Group Inc.
11.11.21 MorphoSys Neutral Goldman Sachs Group Inc.
11.11.21 Sanofi Buy Goldman Sachs Group Inc.
11.11.21 Roche Conviction Buy List Goldman Sachs Group Inc.
11.11.21 Novartis Conviction Buy List Goldman Sachs Group Inc.
11.11.21 GlaxoSmithKline Buy Goldman Sachs Group Inc.
Seite: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | 18 Weiter

Analysensuche

GO
Werbung

Aktuelle News zu

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln